Detalhe da pesquisa
1.
S100A9 protein is a novel ligand for the CD85j receptor and its interaction is implicated in the control of HIV-1 replication by NK cells.
Retrovirology
; 10: 122, 2013 Oct 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-24156302
2.
Isopentenyl pyrophosphate-activated CD56+ {gamma}{delta} T lymphocytes display potent antitumor activity toward human squamous cell carcinoma.
Clin Cancer Res
; 14(13): 4232-40, 2008 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-18594005
3.
Impacts of HIV infection on Vgamma2Vdelta2 T cell phenotype and function: a mechanism for reduced tumor immunity in AIDS.
J Leukoc Biol
; 84(2): 371-9, 2008 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-18495780
4.
Failure to restore the Vgamma2-Jgamma1.2 repertoire in HIV-infected men receiving highly active antiretroviral therapy (HAART).
Clin Immunol
; 128(3): 349-57, 2008 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-18606571
5.
Natural killer cell responses to dendritic cells infected by the ANRS HIV-1 vaccine candidate, MVAHIV.
Vaccine
; 32(43): 5577-84, 2014 Sep 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-25131736
6.
Dynamic shift from CD85j/ILT-2 to NKG2D NK receptor expression pattern on human decidual NK during the first trimester of pregnancy.
PLoS One
; 7(1): e30017, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22242197
7.
Impact of age, gender, and race on circulating γδ T cells.
Hum Immunol
; 71(10): 968-75, 2010 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-20600446
8.
Natural viral suppressors of HIV-1 have a unique capacity to maintain gammadelta T cells.
AIDS
; 23(15): 1955-64, 2009 Sep 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-19609200
9.
Individual Vgamma2-Jgamma1.2+ T cells respond to both isopentenyl pyrophosphate and Daudi cell stimulation: generating tumor effectors with low molecular weight phosphoantigens.
Cancer Immunol Immunother
; 56(6): 819-29, 2007 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-17131122